Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oruka Therapeutics Inc ORKA

Healthcare Biotechnology
Oruka Therapeutics, Inc., formerly ARCA biopharma, Inc., is a biotechnology company. The Company is engaged in developing novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis. It is advancing a proprietary portfolio of potential antibodies that target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. The... see more

Recent & Breaking News (NDAQ:ORKA)

Edison Expands International Renewable Energy Presence With Launch of Full Coverage of Albioma

PR Newswire November 8, 2013

ARCA biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial

Business Wire November 6, 2013

VOLC, GLUU, ABIO and EROC added to NASDAQ Active Stock Watch List at EPR

Accesswire October 29, 2013

ARCA biopharma Announces IND Submission to US FDA for Gencaro for the Treatment of Atrial Fibrillation

Business Wire October 29, 2013

Exclusive Video Interviews With CEOs Now on Equities.com: ABIO, INO, IVX, NETD, OPXA

Globe Newswire September 25, 2013

Robert E. Conway Appointed to ARCA biopharma Board of Directors

Business Wire September 4, 2013

ARCA biopharma to Present at the Rodman & Renshaw Annual Global Investment Conference

Business Wire August 21, 2013

Raymond L. Woosley, M.D., Ph.D. Appointed to ARCA biopharma Board of Directors

Business Wire July 30, 2013

ARCA biopharma Announces Steering Committee for GENETIC-AF Trial

Business Wire July 24, 2013

ARCA biopharma Announces Additions to GENETIC-AF Leadership Team

Business Wire July 22, 2013

ARCA biopharma Provides Business Update

Business Wire July 17, 2013

Gencaro(TM) Potential Efficacy in Preventing Atrial Fibrillation Paper Published in JACC: Heart Failure

Business Wire June 6, 2013

ARCA biopharma Announces Closing of $20 Million Equity Offering

Business Wire June 5, 2013

ARCA biopharma Announces Pricing of $20 Million Equity Offering

Business Wire May 30, 2013

ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic Leader

Business Wire May 6, 2013

InvestorsGuru.com 47 Filtered Mid-Day Market Movers Recap

Investors Guru April 28, 2013

Free Research Reports on ABIO, DCTH, MUX and XIDE Issued by the Bedford Report

Marketwired April 23, 2013

PennyStocks.com Announces Trade Alerts on: LOTE, OCTX, ABIO, and FEEC

Marketwired April 23, 2013

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Business Wire April 22, 2013

MGM Resorts Shares Climb Higher as Billionaire Kerkorian may Boost his Stake. Market Trades Flat on Good Economic Data

PR Newswire March 15, 2013